EPCA ’13: CP Chem alpha olefins plant expansion study in final stages

07 October 2013 12:53  [Source: ICIS news]

BERLIN (ICIS)--Chevron Phillips Chemical (CP Chem) is in the final stages of studies regarding expanding alpha olefins production by at least 20% at its Cedar Bayou, Texas, plant, an executive with the US-based company said on Monday.

CP Chem plans to go to its board for an investment decision on the proposal in the first quarter of 2014, said Mitch Eichelberger, general manager of normal alpha olefins and polyalphaolefins for CP Chem.

He made his comments on the sidelines of the 47th annual European Petrochemical Association (EPCA) meeting.

All the required governmental permits have been filed in regard to the expansion and are awaiting approval, Eichelberger said.

If given full approval, CP Chem would like to complete the expansion by mid-2015, he said.

The expansion would increase production for normal alpha olefins such as 1-hexene, butane and much larger molecules, Eichelberger said.

Current production capacity at the plant is 705,000 tonnes/year, according to the ICIS plants and projects database.

CP Chem is already building a new on-purpose 1-hexene plant at the Cedar Bayou complex.

That plant will have a capacity of up to 250,000 tonnes/year, making it the world’s largest plant of its kind. The plant should start operations in mid-2014.

Normal alpha olefins are used in the production of polyethylene (PE) but can be used in making plasticizers, detergents, synthetic lubricants and waxes, depending on the size of the size of the olefin molecule.

The EPCA conference runs from 5-9 October.

Additional reporting by Al Greenwood

By: Jeremy Pafford
+1 713 525 2653

AddThis Social Bookmark Button

For the latest chemical news, data and analysis that directly impacts your business sign up for a free trial to ICIS news - the breaking online news service for the global chemical industry.

Get the facts and analysis behind the headlines from our market leading weekly magazine: sign up to a free trial to ICIS Chemical Business.

Printer Friendly